Pathological Aggressiveness of Prostatic Carcinomas Related to RNASEL R462Q Allelic Variants

This prospective study suggests that prostate cancer in patients with the R462Q allelic variant of the HPC1/RNASEL gene is not associated with more aggressive clinical or pathological features in radical prostatectomy specimens.